Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

1.9K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.9K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

713
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
713
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

3.2K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.2K
Hemoglobin01:24

Hemoglobin

6.9K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
6.9K
Blood Types02:20

Blood Types

21.9K
Human blood is classified into different types based on the presence of antigens on the red blood cell's surface and antibodies in the plasma. Proper identification of blood type is essential for successful blood transfusion. The International Society of Blood Transfusion has identified 38 human blood types based on the surface antigens on the red blood cells. The most common types are ABO, Rh, and MNS blood types.
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
21.9K
Multiple Allele Traits01:49

Multiple Allele Traits

37.6K
The Concept of Multiple Allelism
37.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "'Erythritol', a safe natural sweetener exhibits multi-stage anti-malarial activity by permeating into Plasmodium falciparum through aquaglyceroporin channel" [Biochem. Pharmacol. 205 (2022) 115287].

Biochemical pharmacology·2026
Same author

Red cell shape regulation by band 3-ankyrin-spectrin linkage: implications for clinical severity of bovine hereditary spherocytosis.

Blood. Red cells & iron·2026
Same author

The red blood cell proteome and interactome identify a Band 3-BLVRB axis regulating hypoxic metabolic adaptation.

Blood·2026
Same author

Stag2 dependent chromatin remodeling enforces the erythroid-specific Gata1 cistrome.

Blood·2026
Same author

Germline TP53 Mutations Causing Diamond-Blackfan Anemia: A French Report.

Pediatric blood & cancer·2026
Same author

Retraction Notice to: Blocking Macrophage Migration Inhibitory Factor Protects Against Cisplatin-Induced Acute Kidney Injury in Mice.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

Blood·2026
Same journal

Identifying steroid-refractory aGVHD before it happens.

Blood·2026
Same journal

ELISA-negative HIT: antibody recognition and relevance.

Blood·2026
Same journal

EBV and immunodeficiency: the odd couple drawn to the brain.

Blood·2026
Same journal

A bone to pick with ferric carboxymaltose.

Blood·2026
Same journal

A step toward streamlining HIT diagnosis.

Blood·2026
See all related articles

Related Experiment Video

Updated: Dec 14, 2025

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.2K

Diamond-Blackfan anemia.

Lydie Da Costa1,2,3, Thierry Leblanc4, Narla Mohandas5

  • 1Service d'Hématologie Biologique, Hôpital Robert-Debré, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Blood
|July 24, 2020
PubMed
Summary
This summary is machine-generated.

Diamond-Blackfan anemia (DBA) is a inherited bone marrow failure syndrome characterized by erythroblastopenia. Molecular insights into DBA pathophysiology are advancing, offering hope for new therapeutic options like gene therapy and drug screening.

More Related Videos

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

10.0K
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

12.1K

Related Experiment Videos

Last Updated: Dec 14, 2025

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.2K
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

10.0K
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

12.1K

Area of Science:

  • Hematology
  • Genetics
  • Molecular Biology

Background:

  • Diamond-Blackfan anemia (DBA) is the first described ribosomopathy, a constitutional inherited bone marrow failure syndrome.
  • It is characterized by severe erythroblastopenia and serves as a model for ribosomal diseases.
  • DBA arises from heterozygous allelic variations in ribosomal protein genes.

Purpose of the Study:

  • To elucidate the molecular basis and pathophysiology of Diamond-Blackfan anemia.
  • To review the current understanding of DBA mechanisms, including nucleolar stress and erythroid tropism.
  • To highlight recent therapeutic advances and future directions for DBA treatment.

Main Methods:

  • Review of existing literature on Diamond-Blackfan anemia.
  • Analysis of molecular mechanisms including ribosomal RNA maturation defects, p53 stabilization, and GATA1/HSP70 involvement.
  • Examination of globin/heme imbalance and reactive oxygen species production in erythropoiesis.

Main Results:

  • Classical DBA involves defects in ribosomal RNA maturation, leading to nucleolar stress, p53 stabilization, cell-cycle arrest, and apoptosis.
  • Erythroid tropism in DBA is influenced by p53-independent pathways, including GATA1/HSP70 interactions and toxic free heme accumulation.
  • These factors contribute to defective erythropoiesis and anemia in DBA patients.

Conclusions:

  • Significant progress has been made in understanding DBA's molecular underpinnings and pathophysiology.
  • Despite limited therapeutic progress historically, recent advances in gene therapy, stem cell transplantation, and drug screening offer new hope.
  • Further research into DBA mechanisms is crucial for developing effective treatments for this rare genetic disorder.